PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
This investigation represents the university’s first human trials involving a Schedule I substance, classified by the federal government as having no accepted medical use.
Psilocybin, commonly known as “shrooms” or “magic mushrooms,” can significantly distort users’ sense of time, mood, and reality, often causing hallucinations.
Read moreA recent case study has highlighted the potential of using MDMA and psilocybin to manage these persistent symptoms.
Read moreHere’s a wonderful article on how people with cluster headaches became unexpected psychedelic pioneers.
Read moreA recent study has challenged the prevailing belief that childhood trauma influences the experiences individuals have with ayahuasca, a psychoactive brew traditionally used by Indigenous cultures for spiritual and healing purposes.
Read moreOprah’s website OprahDaily.com has published a guide to psychedelics and psychedelic-assisted therapy.
Read moreThis psychiatric disorder, known for its high mortality rate, has long been a challenging condition to treat effectively.
The research, conducted at Monash University, revealed that psilocybin could improve cognitive flexibility and help maintain body weight in an animal model of AN.
Read moreRandomized clinical trials demonstrated the efficacy of psilocybin in reducing symptom severity in depression and MDMA in reducing PTSD symptomatology.
Furthermore, psychedelics often produce subjective effects (such as transcendence, mystical experiences, and a sense of oneness) that may be uniquely relevant to the existential distress experienced in PGD.
Read moreReference to an intrinsic healing mechanism or an ‘inner healer’ is commonplace amongst psychedelic users.
Read moreIn a new study, researchers found that psychological flexibility, several facets of mindfulness, and values-congruent living significantly improved following psilocybin and were maintained through week 16.
Additionally, improvements in psychological flexibility and experiential acceptance were strongly associated with reductions in depression severity following psilocybin.
Keep reading for the full article at Nature.com
Read morePsychedelic music session playlists have been utilized consistently for modern psychedelic-assisted therapy clinical trials, and more recently researchers at Johns Hopkins University and Imperial College of London have specifically studied the effect of these music playlists on participants in trials.
Read moreBig news- a collaborative effort among scientists from the University of Texas at Arlington, Scottsdale Research Institute in Phoenix, Shimadzu Scientific Instruments in Maryland, and Millipore-Sigma in Round Rock, Texas, has led to the development of a new method for quantifying the potency of psilocybin and psilocin.
Read more